Shin Nippon Biomedical Laboratories, Ltd
Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, provides drug discovery and development services in Japan, the United States, China, Cambodia, India, and internationally. The company offers pre-clinical laboratory services, such as Good Laboratory Practice inspections; general and specific toxicity studies; pathological examinations; PK/PD of biopharmaceuticals, immunotoxicity tests, and antibody production; reproductive and developmental toxicity studies; pharmacological efficacy studies; analytical studies; and clinical pathology. It also engages in the establishment and validation of analytical methods, analysis of biological samples, and calculation of pharmacokinetic parameters; and provides absorption, distribution, metabolism, and excretion studies using radioisotope-labeled compounds. In addition, the company offers site management organization services for clinical trials; clinical contract research organization services; and translational research services, including research and development of nasal delivery systems, nucleic acid adjuvants, and regenerative medicines. Shin Nippon Biomedical Laboratories, Ltd. was founded in 1957 and is headquartered in Tokyo, Japan. Show More...
-
Website http://www.snbl.co.jp
-
Sector Healthcare
-
Industry Diagnostics & Research
-
Last Quote 8.25 EUR
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-03 2011-03 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 TTM Earnings Per Share JPY 16.14 -43.25 -96.2 -33.56 -20.11 -34.83 66.52 -22.18 -85.41 46.84 47.8 Dividends JPY 3.0 3.0 3.0 Payout Ratio % * 6.3 Shares Mil 33.0 33.0 34.0 34.0 38.0 40.0 40.0 41.0 42.0 42.0 42.0 Book Value Per Share * EUR 1.94 1.53 0.67 1.61 1.72 3.34 3.9 4.23 6.08 3.5 Free Cash Flow Per Share * EUR -0.16 -0.35 -0.29 -0.45 -0.6 -0.85 -0.9 -0.03 0.32 Return on Assets % 1.3 -3.58 -9.11 -3.45 -2.07 -3.44 5.96 -1.75 -6.25 3.48 4.1 Financial Leverage (Average) 4.31 4.95 8.46 12.15 3.83 4.22 2.93 2.51 2.2 1.91 2.26 Return on Equity % 5.65 -16.45 -55.94 -34.31 -11.48 -13.82 20.31 -4.71 -14.63 7.15 8.16 Return on Invested Capital % 2.52 -3.94 -11.16 -3.65 -1.85 -3.74 8.11 -1.58 -7.31 4.92 5.57 Interest Coverage 2.2 -2.32 -8.25 -0.69 1.31 -0.37 12.67 -1.02 -3.03 5.37 9.15 Current Ratio 1.44 1.33 1.12 0.87 1.18 0.98 0.84 0.92 0.76 0.66 0.88 Quick Ratio 0.84 0.76 0.64 0.56 0.79 0.54 0.41 0.52 0.39 0.4 0.5 Debt/Equity 1.74 2.03 3.79 4.97 1.28 1.2 0.73 0.5 0.28 0.16 0.5